Sevelabind 400mg Tablet, also known as Sevelabind-400 Tablet 10's or SEVELABIND 400 TABLET, is a medication categorized as a phosphate binder. This medication is specifically designed to address elevated levels of phosphate in the blood, a condition known as hyperphosphatemia. It is commonly prescribed for adult patients undergoing dialysis due to chronic kidney disease and bone-related issues.

The active ingredient in Sevelabind 400mg Tablet is sevelamer, which functions by binding to phosphate in the gastrointestinal tract, thereby reducing its absorption into the body. By effectively lowering excessive phosphate levels in the bloodstream, this medication plays a vital role in preventing the harmful accumulation of phosphate, promoting bone health, and reducing the risk of cardiovascular diseases like heart disease and strokes.

Patients are advised to adhere strictly to the dosage and duration prescribed by their healthcare provider for optimum results. It is crucial to take Sevelabind 400mg Tablet with food and at regular intervals each day. However, like any medication, Sevelabind 400mg Tablet may induce certain side effects such as nausea, vomiting, abdominal discomfort, constipation, and diarrhea. Additionally, deficiencies in calcium, folic acid, and essential vitamins such as A, D, E, and K may occur, necessitating the use of supplementary measures as directed by a healthcare professional.

Individuals with a history of allergies to any of the medication's components, low blood phosphate levels, or bowel obstruction are advised against the use of Sevelabind 400mg Tablet. Furthermore, caution should be exercised by patients experiencing difficulties in swallowing, stomach and bowel motility issues, or those who have undergone major stomach or bowel surgeries.

Special consideration should be given to pregnant and breastfeeding women before using Sevelabind 400mg Tablet, with prior consultation with a medical practitioner being highly recommended. It is essential to note that Sevelabind 400mg Tablet is not intended for use in children and adolescents under the age of 18.

Regular monitoring and adherence to dietary recommendations set forth by healthcare providers are essential components of Sevelabind 400mg Tablet therapy to ensure the safe and effective management of high phosphate levels in patients with chronic kidney disease undergoing dialysis.